368 related articles for article (PubMed ID: 28424327)
1. RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury.
Fischer JC; Bscheider M; Eisenkolb G; Lin CC; Wintges A; Otten V; Lindemans CA; Heidegger S; Rudelius M; Monette S; Porosnicu Rodriguez KA; Calafiore M; Liebermann S; Liu C; Lienenklaus S; Weiss S; Kalinke U; Ruland J; Peschel C; Shono Y; Docampo M; Velardi E; Jenq RR; Hanash AM; Dudakov JA; Haas T; van den Brink MRM; Poeck H
Sci Transl Med; 2017 Apr; 9(386):. PubMed ID: 28424327
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells.
Fischer JC; Bscheider M; Göttert S; Thiele Orberg E; Combs SE; Bassermann F; Heidegger S; Haas T; Poeck H
Sci Rep; 2019 Oct; 9(1):14955. PubMed ID: 31628411
[TBL] [Abstract][Full Text] [Related]
3. STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.
Wu Y; Tang CA; Mealer C; Bastian D; Hanief Sofi M; Tian L; Schutt S; Choi HJ; Ticer T; Zhang M; Sui X; Huang L; Mellor AL; Hu CA; Yu XZ
Cell Mol Immunol; 2021 Mar; 18(3):632-643. PubMed ID: 33500563
[TBL] [Abstract][Full Text] [Related]
4. Regeneration After Radiation- and Immune-Mediated Tissue Injury Is Not Enhanced by Type III Interferon Signaling.
Fischer JC; Lin CC; Heidegger S; Wintges A; Schlapschy M; Beudert M; Combs SE; Bassermann F; Skerra A; Haas T; Poeck H
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):970-976. PubMed ID: 30503785
[TBL] [Abstract][Full Text] [Related]
5. Retinoic Acid Signaling Modulates Recipient Gut Barrier Integrity and Microbiota After Allogeneic Hematopoietic Stem Cell Transplantation in Mice.
Pan P; Atkinson SN; Taylor B; Zhu H; Zhou D; Flejsierowicz P; Wang LS; Morse M; Liu C; Gunsolus IL; Chen X
Front Immunol; 2021; 12():749002. PubMed ID: 34759928
[TBL] [Abstract][Full Text] [Related]
6. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium.
Broquet AH; Hirata Y; McAllister CS; Kagnoff MF
J Immunol; 2011 Feb; 186(3):1618-26. PubMed ID: 21187438
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
8. Both STING and MAVS fish orthologs contribute to the induction of interferon mediated by RIG-I.
Biacchesi S; Mérour E; Lamoureux A; Bernard J; Brémont M
PLoS One; 2012; 7(10):e47737. PubMed ID: 23091644
[TBL] [Abstract][Full Text] [Related]
9. Findings May Lead to New Strategies for GVHD.
Cancer Discov; 2017 Jul; 7(7):OF2. PubMed ID: 28559402
[TBL] [Abstract][Full Text] [Related]
10. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
[TBL] [Abstract][Full Text] [Related]
12. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
13. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
[TBL] [Abstract][Full Text] [Related]
14. RIG-I Signaling via MAVS Is Dispensable for Survival in Lethal Influenza Infection
Wu W; Wang X; Zhang W; Tian L; Booth JL; Duggan ES; More S; Liu L; Dozmorov M; Metcalf JP
Mediators Inflamm; 2018; 2018():6808934. PubMed ID: 30532653
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
16. Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells.
Proenca-Modena JL; Sesti-Costa R; Pinto AK; Richner JM; Lazear HM; Lucas T; Hyde JL; Diamond MS
J Virol; 2015 May; 89(9):4720-37. PubMed ID: 25717109
[TBL] [Abstract][Full Text] [Related]
17. A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.
Dutta M; Robertson SJ; Okumura A; Scott DP; Chang J; Weiss JM; Sturdevant GL; Feldmann F; Haddock E; Chiramel AI; Ponia SS; Dougherty JD; Katze MG; Rasmussen AL; Best SM
Cell Rep; 2017 Jan; 18(3):816-829. PubMed ID: 28099857
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease.
Eriguchi Y; Uryu H; Nakamura K; Shimoji S; Takashima S; Iwasaki H; Miyamoto T; Shimono N; Hashimoto D; Akashi K; Ayabe T; Teshima T
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1525-9. PubMed ID: 23927965
[TBL] [Abstract][Full Text] [Related]
19. Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.
Swimm A; Giver CR; DeFilipp Z; Rangaraju S; Sharma A; Ulezko Antonova A; Sonowal R; Capaldo C; Powell D; Qayed M; Kalman D; Waller EK
Blood; 2018 Dec; 132(23):2506-2519. PubMed ID: 30257880
[TBL] [Abstract][Full Text] [Related]
20. Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs.
Ranoa DR; Parekh AD; Pitroda SP; Huang X; Darga T; Wong AC; Huang L; Andrade J; Staley JP; Satoh T; Akira S; Weichselbaum RR; Khodarev NN
Oncotarget; 2016 May; 7(18):26496-515. PubMed ID: 27034163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
